Trials
Search / Trial NCT06436599

Comparison of Analgesic Efficacy of Serratus Anterior Plan Block and Serratus Posterior Superior Intercostal Plan Block in Breast Surgery

Launched by MUSTAFA BURGAC · May 28, 2024

Trial Information

Current as of February 08, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to manage pain after breast surgery. Specifically, it compares two types of nerve blocks—Serratus Anterior Plane Block and Serratus Posterior Superior Intercostal Plane Block—to see which one works better to relieve pain after a mastectomy. The goal is to help patients recover with less pain, reduce the need for strong pain medications, and shorten their hospital stay.

To participate in this trial, you should be a female patient aged between 18 and 74, planning to have a unilateral mastectomy (which means surgery on one breast). You should be in generally good health, classified as ASA I-III, which refers to your physical status. However, you cannot join if you have certain conditions like bleeding disorders, infections near the injection site, allergies to local anesthetics, or if you are pregnant. If you decide to participate, you can expect close monitoring and care to ensure your comfort and safety during your recovery process.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • unilateral mastectomy
  • ASA I-III risk group
  • Exclusion Criteria:
  • Coagulopathy
  • Wound and infection in the block area
  • Local anaesthetic allergy
  • Mental retardation
  • Non-cooperative
  • Pregnant patients

About Mustafa Burgac

Mustafa Burgac is a dedicated clinical trial sponsor committed to advancing medical research through innovative and ethically conducted studies. With a focus on delivering high-quality clinical trials, Burgac emphasizes collaboration with healthcare professionals and research institutions to ensure rigorous scientific standards and patient safety. The organization is adept at navigating complex regulatory environments and is driven by a mission to bring new therapies to market, ultimately improving patient outcomes and enhancing the quality of healthcare.

Locations

İstanbul, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0